Publicaciones (92) Publicaciones de CARLOS GOMEZ ALONSO

2024

  1. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care

    Nefrologia , Vol. 44, Núm. 2, pp. 241-250

  2. Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 4, pp. 618-626

  3. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

  2. Transition of patients with metabolic bone disease from paediatric to adult healthcare services: current situation and proposals for improvement

    Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1

2022

  1. A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial

    BMC medicine, Vol. 20, Núm. 1, pp. 83

  2. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  3. Low-density granulocytes: A new marker of bone deterioration in patients on peritoneal dialysis

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 4, pp. 107-114

  4. Osteoporosis in chronic kidney disease: A essential challenge

    Medicina Clinica, Vol. 158, Núm. 1, pp. 27-34

  5. Position of the Spanish Society of Rheumatology (SER) and the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM) on romosozumab

    Reumatologia Clinica, Vol. 18, Núm. 7, pp. 383-386

  6. Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

    Journal of Bone and Mineral Research

2021

  1. Association of biochemical parameters of bone metabolism with progression and/or development of new aortic calcifications

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 1, pp. 10-16

  2. COVID-19 and Vitamin D. Position paper of the Spanish society for bone research and mineral metabolism (SEIOMM)

    Revista de Osteoporosis y Metabolismo Mineral

  3. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial

    Journal of Bone and Mineral Research, Vol. 36, Núm. 10, pp. 1967-1978

  4. Multiple vertebral fractures after suspension of denosumab. A series of 56 cases

    International Journal of Clinical Practice, Vol. 75, Núm. 10

  5. The Non-invasive Diagnosis of Bone Disorders in CKD

    Calcified Tissue International, Vol. 108, Núm. 4, pp. 512-527

2020

  1. Effect of frailty and sarcopenia on the risk of falls and oste oporotic fractures in anun selected population

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 12, Núm. 3, pp. 81-86

  2. Impact of vascular calcification on bone health and mortality in kidney transplant patients

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 12, Núm. 2, pp. 53-61

  3. Is vitamin-D supplementation not useful in patients at risk of fractures and falls?

    Gynecological Endocrinology, Vol. 36, Núm. 2, pp. 93-95

  4. Paediatric Metabolic Bone Disease: A Lifetime Ahead

    Advances in Therapy, Vol. 37, pp. 38-46